10. Brooks PC, Montgomery https://www.selleckchem.com/products/MDV3100.html AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994,79(7):1157–1164.CrossRef 11. Ng QK, Sutton MK, Soonsawad P, Xing L, Cheng H,

Segura T: Engineering clustered ligand binding into nonviral vectors: alphavbeta3 targeting as an example. Mol Ther 2009,17(5):828–836.CrossRef 12. Guzzetti I, Civera M, Vasile F, Araldi EM, Belvisi L, Gennari C, Potenza D, Fanelli R, Piarulli U: Determination of the binding epitope of RGD-peptidomimetics to alphavbeta3 and alpha(IIb)beta3 integrin-rich intact cells by NMR and computational studies. Org Biomol Chem 2013,11(23):3886–3893.CrossRef 13. Jain KK: Nanomedicine: application of nanobiotechnology in medical practice. PP2 in vitro Med Princ Pract 2008,17(2):89–101.CrossRef 14. Song H, Cao XF, Ruan J, Peng X, Wang J, Wang C, Bao CC: Application of rotatable central composite design in the preparation and optimization of poly (lactic-co-glycolic acid) nanoparticles for controlled delivery of HSA. Nano Biomed Eng 2011,147(927):258–267.

15. Yu D, Amano C, Fukuda T, Yamada T, Kuroda S, Tanizawa K, Kondo A, Ueda M, Yamada H, Tada H, Seno M: The specific delivery of proteins to human liver cells by engineered bio-nanocapsules. FEBS J 2005,272(14):3651–3660.CrossRef 16. Shishido T, Muraoka M, Ueda M, Seno M, Tanizawa K, Kuroda S, Fukuda H, Kondo A: Secretory production system of bionanocapsules using a stably transfected insect cell line. Appl Microbiol Biotechnol 2006,73(3):505–511.CrossRef 17. Chen LS, Wang M, Ou WC, Fung CY, Chen PL, Chang CF, Huang WS, Wang JY, Lin PY, Chang D: Efficient gene transfer using the human JC virus-like particle that inhibits human colon adenocarcinoma growth in a nude mouse model. Gene Ther 2010,17(8):1033–1041.CrossRef 18. Wu Z, Li X, Sunkara M, Spearman H, Morris AJ, Huang C: PIPKIgamma regulates focal adhesion dynamics and colon cancer cell invasion. PLoS One 2011,6(9):e24775.CrossRef 19. Sidky YA, Borden EC: Inhibition of angiogenesis by

interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 1987,47(19):5155–5161. Org 27569 20. Frassoldati A, Lamparelli T, Federico M, Annino L, Capnist G, Pagnucco G, Dini E, Resegotti L, MK 8931 datasheet Damasio EE, Silingardi V: Hairy cell leukemia: a clinical review based on 725 cases of the Italian cooperative group (ICGHCL). Italian cooperative group for hairy cell leukemia. Leuk Lymphoma 1994,13(3–4):307–316.CrossRef 21. Hernberg M, Pyrhonen S, Muhonen T: Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: an overview of randomized trials. J Immunother 1999,22(2):145–154.CrossRef 22. Zeltins A: Construction and characterization of virus-like particles: a review. Mol Biotechnol 2013,53(1):92–107.CrossRef 23. Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM: Structural biology of hepatitis C virus. Hepatology 2004,39(1):5–19.